Antiviral signaling of a type III CRISPR-associated deaminase
- 21 February 2025
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 387 (6736) , eadr0393
Abstract
Prokaryotes have evolved diverse defense strategies against viral infection, including foreign nucleic acid degradation by CRISPR-Cas systems and DNA and RNA synthesis inhibition through nucleotide pool depletion. Here, we report an antiviral mechanism of type III CRISPR-Cas–regulated adenosine triphosphate (ATP) depletion in which ATP is converted into inosine triphosphate (ITP) by CRISPR-Cas–associated adenosine deaminase (CAAD) upon activation by either cA 4 or cA 6 , followed by hydrolysis into inosine monophosphate (IMP) by Nudix hydrolase, ultimately resulting in cell growth arrest. The cryo–electron microscopy structures of CAAD in its apo and activated forms, together with biochemical evidence, revealed how cA 4 or cA 6 binds to the CRISPR-associated Rossmann fold (CARF) domain and abrogates CAAD autoinhibition, inducing substantial conformational changes that reshape the structure of CAAD and induce its deaminase activity. Our results reveal the mechanism of a CRISPR-Cas–regulated ATP depletion antiviral strategy.Keywords
This publication has 65 references indexed in Scilit:
- A conserved family of immune effectors cleaves cellular ATP upon viral infectionCell, 2023
- A host of armor: Prokaryotic immune strategies against mobile genetic elementsCell Reports, 2023
- Cryo-EM structure of the RADAR supramolecular anti-phage defense complexCell, 2023
- Molecular basis of RADAR anti-phage supramolecular assembliesCell, 2023
- UCSF ChimeraX: Structure visualization for researchers, educators, and developersProtein Science, 2020
- MolProbity: More and better reference data for improved all‐atom structure validationProtein Science, 2017
- Spatiotemporal Control of Type III-A CRISPR-Cas Immunity: Coupling DNA Degradation with the Target RNA RecognitionMolecular Cell, 2016
- Degradation of Phage Transcripts by CRISPR-Associated RNases Enables Type III CRISPR-Cas ImmunityCell, 2016
- Structures of Substrate- and Inhibitor-Bound Adenosine Deaminase from a Human Malaria Parasite Show a Dramatic Conformational Change and Shed Light on Drug SelectivityJournal of Molecular Biology, 2008
- Adenosine deaminase: Functional implications and different classes of inhibitorsMedicinal Research Reviews, 2001